Literature DB >> 6945606

HLA antigens and subtypes of schizophrenia.

P McGuffin, A E Farmer, A H Yonace.   

Abstract

Studies on HLA antigens in schizophrenia have produced conflicting results, but there has been greater agreement when clinical subtypes of the disorder have been separated. In view of this, we reassessed 68 previously studied patients with hospital diagnoses of schizophrenia and, while blind to their HLA types, used operational criteria to define clinical subtypes. We compared and combined the results with those from all available similar studies. Those of our patients who fulfilled operational criteria for paranoid schizophrenia showed a nonsignificant increase in HLA A9 as compared with controls. The magnitude of the increase was similar to that from all previous reports, and when data from all sources were combined, the evidence for an association between HLA A9 and paranoid schizophrenia was consistent and highly significant. Patients who were diagnosed as suffering from hebephrenic schizophrenia showed significant increases in HLA A1 and B8 compared with controls. An association between hebephrenia and A1, but not B8, remained on combining the results with those of other studies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945606     DOI: 10.1016/0165-1781(81)90041-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

Review 1.  DNA and classical genetic markers in schizophrenia.

Authors:  M J Owen; P McGuffin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

2.  HLA antigens in schizophrenia, major depressive disorder, and schizoaffective disorder.

Authors:  M Rösler; W Bellaire; N Gressnich; D Giannitsis; A Jarovici
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

Review 3.  Multiple Sclerosis and Schizophrenia.

Authors:  Borros M Arneth
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.